Abstract

Furthermore, of the 101 synthetic overlapping BSA peptides screened, two HLA-DRB1*01:01-restricted epitopes were identified. Thus, caution should be exercised when FCS-containing culture media is used for T cell clinical trial monitoring

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call